Australia as a base of research excellence Some mid sized pharma and biotech companies still have limited experience running their clinical research outside the traditional regions within the US or Europe.
The aim of this webinar is to highlight Australia's capability in early and late stage research. We will also discuss leveraging Australia’s R&D tax incentive to minimize the cost of these activities.
Join this webinar to understand how you can access Australia's expedited pathways, quality resources and infrastructure and experience in working with Asia.
Marisa Petersen,
Managing Director, George Clinical
Marisa is the Managing Director of George Clinical, the clinical trial delivery arm of The George Institute for Global Health. Marisa completed her pharmacy degree at the University of Sydney and continued her studies with a PhD in Clinical Pharmacology and Pharmacokinetics.
Marisa has worked for over 20 years in the pharmaceutical industry, fulfilling roles in Regulatory Affairs, Clinical Research and Project Management. Prior to joining George Clinical, Marisa was the Vice President Asia Pacific for Omnicare Clinical Research, a global CRO, taking responsibility for the delivery of trials in the Asia-Pacific region and developing a network of offices across the region to effectively service customer needs. Marisa has a strong association with ARCS in Australia and Asia (an organisation similar to DIA in its goals) and is a member of the PIC R&D Taskforce.
Bev Thomas,
Chief Executive Officer, Nucleus Network
Bev is the CEO of Nucleus Network, Australia's leading Phase I clinical trials organisation. Prior to becoming CEO, Bev was responsible for Scientific Affairs at Nucleus Network. Bev is a registered pharmacist and has worked at Australian start-up companies and in Venture Capital since 1999, assisting with transitioning drug technologies into the clinic. Bev has a PhD in gene therapy from the University of Bath, post-doctoral experience in pharmaceutical formulation and a MBA in Technology Management.
Marc Peskett,
Director, MPR Group
Marc is an advisor to fast growing start-ups and entrepreneurial enterprises, specialising in venture planning, business and investment ready services, R&D Tax Incentive advice, funding, business structuring, financial analysis and modelling. His financial expertise and business advice has led to Marc being invited by clients to join their advisory boards. Participating on a number of clients' boards sees Marc adopting an active role in decision making and monitoring progress towards the achievement of long-term growth and profit objectives.
- Understanding and leveraging the right contracting approach
- Understand industry dynamics that impact your contracting
- The way to the future – data, technology, tools, people resources
- Cost saving solutions
- VP
- Director
- Managers of Managed Markets
- Manager of Contract Operations
- Contract Strategy VP
- Manager of Finance
- Contracts
- Managed Care
- Rebates
- Chargebacks Managers
